ArticleSource code for biology and medicine2015
FlexDM: Simple, parallel and fault-tolerant data mining using WEKA.
Article in Source code for biology and medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of Knee Osteoarthritis Based on Bayesian Network: Pilot Study.JMIR medical informatics · 2019Article
- Community-led data collection using Open Data Kit for surveillance of animal African trypanosomiasis in Shimba hills, Kenya.BMC research notes · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith the continued exponential growth in data volume, large-scale data mining and machine learning experiments have become a necessity for many researchers without programming or statistics backgrounds. WEKA (Waikato Environment for Knowledge Analysis) is a gold standard framework that facilitates and simplifies this task by allowing specification of algorithms, hyper-parameters and test strategies from a streamlined Experimenter GUI. Despite its popularity, the WEKA Experimenter exhibits several limitations that we address in our new FlexDM software.
resultsFlexDM addresses four fundamental limitations with the WEKA Experimenter: reliance on a verbose and difficult-to-modify XML schema; inability to meta-optimise experiments over a large number of algorithm hyper-parameters; inability to recover from software or hardware failure during a large experiment; and failing to leverage modern multicore processor architectures. Direct comparisons between the FlexDM and default WEKA XML schemas demonstrate a 10-fold improvement in brevity for a specification that allows finer control of experimental procedures. The stability of FlexDM has been tested on a large biological dataset (approximately 450 k attributes by 150 samples), and automatic parallelisation of tasks yields a quasi-linear reduction in execution time when distributed across multiple processor cores.
conclusionFlexDM is a powerful and easy-to-use extension to the WEKA package, which better handles the increased volume and complexity of data that has emerged during the 20 years since WEKA's original development. FlexDM has been tested on Windows, OSX and Linux operating systems and is provided as a pre-configured virtual reference environment for trivial usage and extensibility. This software can substantially improve the productivity of any research group conducting large-scale data mining or machine learning tasks, in addition to providing non-programmers with improved control over specific aspects of their data analysis pipeline via a succinct and simplified XML schema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.